the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
October 05, 2016 – Here, we make available to our readers a Drug Safety Communication by the American Food & Drug Administration (FDA), where FDA warns about the risk of hepatitis B virus (HBV) reactivation in some patients treated with …
July 09, 2014 – A very exiting review article in the British Medical Journal (BMJ) on July 07, 2014 discusses the newest developments in the treatment options in HCV infection. This is an excerpt from the article, which can be …
Newest developments in antiviral treatment options in hepatitis C virus infection (HCV) Read more »